Global pharmaceutical major Lupin Limited has announced that its greenhouse gas emissions reduction targets have been officially validated by the Science Based Targets initiative. The validation covers Scope 1, Scope 2 and Scope 3 emissions, aligning Lupin’s climate strategy with the Paris Agreement goal of limiting global temperature rise to 1.5°C.

The validation marks a significant milestone in Lupin’s sustainability journey and places the company among a select group of organisations to achieve comprehensive Science Based Targets initiative approval across all emission scopes within a year of setting its climate targets. It reflects Lupin’s commitment to science-led climate action and long-term environmental responsibility.

As part of its short-term climate goals, Lupin has committed to reducing absolute Scope 1 and Scope 2 greenhouse gas emissions by 42 per cent by FY 2030, using FY 2023 as the base year. In addition, the company aims to reduce Scope 3 emissions by 61.07 per cent by FY 2033, with FY 2024 as the baseline. Scope 3 reductions will span purchased goods and services, fuel- and energy-related activities, upstream and downstream transportation and distribution, business travel, employee commuting, processing and use of sold products, and franchises.

These targets are aligned with the 1.5°C pathway and have been validated under the Science Based Targets initiative’s latest guidelines, positioning Lupin as an active contributor to global climate mitigation efforts.

Commenting on the validation, Ramesh Swaminathan, executive director, global chief financial officer, and head of IT and API Plus strategic business unit at Lupin, said the approval reinforces the company’s commitment to reducing emissions through a disciplined, science-driven approach. He added that sustainability is being embedded into Lupin’s financial and operational strategies, guiding investments in renewable energy, energy efficiency and low-carbon technologies across its global operations.

Swaminathan further noted that proactive climate action is essential not only to mitigate risks and optimise costs, but also to unlock opportunities for innovation and long-term growth.

The Science Based Targets initiative is a global body that defines and promotes best practices in science-based emissions reduction targets and independently evaluates corporate climate commitments.